Metagenomic Next-Generation Sequencing for Accurate Diagnosis of Pneumocystis jirovecii Pneumonia: A Comparative Study with Traditional Methods
Wentao Luo,Xiuwen Lin,Yuchong Chen,Wenfeng Luo,Huagen Zhang
DOI: https://doi.org/10.2147/idr.s459722
2024-07-13
Infection and Drug Resistance
Abstract:Wentao Luo, 1 Xiuwen Lin, 1 Yuchong Chen, 2 Wenfeng Luo, 3 Huagen Zhang 1 1 The Third Department of Critical Care Medicine, Meizhou People's Hospital, Meizhou, Guangdong, 514000, People's Republic of China; 2 The Fourth Department of Critical Care Medicine, Meizhou People's Hospital, Meizhou, Guangdong, 514000 People's Republic of China; 3 Department of Respiratory and Critical Care Medicine, Meizhou People's Hospital, Meizhou, Guangdong, 514000, People's Republic of China Correspondence: Huagen Zhang, The Third Department of Critical Care Medicine, Meizhou People's Hospital, Meizhou, Guangdong, 514000, People's Republic of China, Tel +8613549175546, Email Background: Metagenomic next-generation sequencing (mNGS) is a high-throughput sequencing technique that identifies a wide array of pathogens directly from clinical specimens. This study evaluates the diagnostic value of mNGS in Pneumocystis jirovecii pneumonia (PJP) and compares its efficacy with traditional detection methods, including Grocott's Methenamine Silver (GMS) staining, serum (1– 3)-β-D-Glucan (BDG) testing, and Lactate Dehydrogenase (LDH) testing. Methods: Seventy-eight patients hospitalized between January 2022 and March 2023 with suspected pulmonary infections were included. Patients were eligible for mNGS if they exhibited symptoms such as fever, cough, dyspnea, or progressive hypoxemia, and met specific clinical criteria for PJP. Specimens obtained included bronchoalveolar lavage fluid, sputum, and peripheral blood. Positive rates and pathogen distributions detected by mNGS and traditional methods were compared. Results: In the PJP group, 25%, 37.5%, and 9.38% of patients had solid organ tumors, corticosteroid use, and skin diseases, respectively, significantly higher than in the non-PJP group. The sensitivity and specificity of mNGS were both 100%, significantly higher than those of serum BDG (sensitivity 50%, specificity 81.8%) and LDH (sensitivity 9.3%, specificity 91.3%). Significant differences in microbial composition between the PJP and Non-PJP groups were observed. mNGS detected multiple mixed pathogens in 96.88% of PJP cases, with 68.75% exhibiting mixed bacterial and viral infections. Notably, 71% of patients improved following antibacterial treatment based on mNGS results. Conclusion: mNGS technology shows superior sensitivity and specificity in diagnosing PJP and guides precise treatment for complex pulmonary infections. Keywords: mNGS, Pneumocystis jirovecii pneumonia, pulmonary infections, dominant pathogens, sensitivity Pneumocystis jirovecii pneumonia (PJP) is an opportunistic, pathogenic fungal infection caused by Pneumocystis jirovecii and is the most commonly observed concurrent infection in patients with AIDS. 1 Epidemiological data on PJP in non-HIV Chinese patients indicate that this opportunistic infection is increasingly seen among immunocompromised individuals due to conditions such as hematological malignancies, solid organ transplants, and the use of immunosuppressive therapies. 2,3 Eighty percent of patients with AIDS experience PJP at a certain stage or at the end of the disease, and 24% of patients with AIDS die directly from PJP. 4 Due to the wide application of immunosuppressants, the incidence of PJP in patients with non-HIV-infected malignant tumors, hematological diseases, or autoimmune diseases has been increasing. 5–7 Patients not infected with AIDS but diagnosed with PJP have a more insidious onset, faster progression, and higher mortality rate than patients with PJP with concurrent HIV infection do. 8,9 Because Pneumocystis jirovecii cannot be grown in vitro in culture media, the current gold standard for diagnosing PJP is the detection of characteristic cysts or trophoblasts in lower respiratory tract specimens by using staining microscopy. Although traditional hexamine silver staining microscopy can diagnose PJP by detecting cysts or trophozoites, qPCR detection can confirm the diagnosis, and combined with serum (1-3)-β-D-glucan (BDG) levels, it can improve diagnostic accuracy. 10 However, traditional methods can result in missed diagnoses. The symptoms of patients not infected with HIV but diagnosed with PJP were more severe, and the hospitalization rate in the intensive care unit was higher. Therefore, early diagnosis and standardized treatment with sensitive antibiotics are more important. 11 Metagenomic next-generation sequencing (mNGS) is a high throughput sequencing technique that does not rely on culture to directly extract nucleic acids from clinical specimens for pathogen detection. 12 Its advantages a -Abstract Truncated-
pharmacology & pharmacy,infectious diseases